These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4279362)

  • 1. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
    Bompani R; Violi G
    Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
    Ciammaichella A; Solitro A; Torcia L; Arcuri P
    Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the lipid pattern after administration of glucuronyl-glucosaminoglycan sulfate (3 GS) inpatients with with acute coronary syndromes].
    Gallone S; Mangiameli D; Vanaria F; Branca D; Lombardo D
    Boll Soc Ital Cardiol; 1975; 20(4):309-14. PubMed ID: 133704
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U; Bastoni F; Gibelli A
    Clin Ter; 1974 Oct; 71(1):13-31. PubMed ID: 4138995
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
    Ferlito S; La Spina E; Cultrera E; Puleo F; Carrà G
    Arch Sci Med (Torino); 1982; 139(2):175-81. PubMed ID: 7138283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of blood lipid fractions produced by phosphatidyl choline in patients with atherosclerosis].
    Caruzzo C; Enrico-Bena L; Carnaghi R
    Minerva Med; 1969 Apr; 60(34):1643-52. PubMed ID: 5770941
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombogenic action of a new extract: 3GS].
    Rusconi C; Orlando G
    Minerva Cardioangiol; 1975 Sep; 23(9):565-70. PubMed ID: 125860
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of purified phospholipids on the serum lipid pattern].
    Tralli G
    Clin Ter; 1977 Mar; 80(6):545-51. PubMed ID: 862355
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use in geriatrics of a preparation with antisclerotic action. (Preliminary results)].
    Solaro F; Corletto F; Dinale M
    G Gerontol; 1969 Aug; 17(8):801-7. PubMed ID: 5371743
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of oral administration of a sulfo-polysaccharide of low molecular weight in a group of sedentary workers with ateriosclerotic cardiovascular disease].
    Alessandri M; Fiorentini P; Garagnani C
    G Clin Med; 1967 Sep; 48(9):935-47. PubMed ID: 4180085
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
    Rugginenti
    Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
    Capone-Braga M; Tellini L; Boncompagni L; Bettoni M; Burali A; Bensi A
    Clin Ter; 1987 Jan; 120(1):25-31. PubMed ID: 2973852
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulodexide in the therapy of vasculopathies].
    Postiglione F; Pisani P; Gisonni P; Perrotta P; Gisonni A; Canciello M; Napolitano L; Brighina G; Ragno I; Salzano A
    Clin Ter; 1986 May; 117(3):223-31. PubMed ID: 3524974
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
    Castello S
    Clin Ter; 1971 Aug; 58(4):323-34. PubMed ID: 4258171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of the thromboelastogram (TEG) in arteriosclerotic subjects treated with natural mucopolysaccharide substances].
    Garbagnati N; Iaschi P; Ciavarelli F; Carignola W
    Clin Ter; 1969 Jul; 50(2):125-31. PubMed ID: 4243098
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of blood lipids in coronary sclerosis and cerebrosclerosis].
    Keller L; Fischer J; Farádi A
    Orv Hetil; 1974 Jun; 115(23):1323-7. PubMed ID: 4840692
    [No Abstract]   [Full Text] [Related]  

  • 20. [The behavior of some metabolic and instrumental parameters in diabetics with arteriopathy of the lower extremities treated with increasing doses of glucuronyl-glycosaminoglycano-sulfate].
    Marigo S
    Clin Ter; 1980 Jun; 93(5):503-18. PubMed ID: 7428314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.